Maureen Mays
Family Medicine · Portland, ORNPI 1164589818
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $20,760 of the $24,363 with a category attached, or 85.2%. Amgen accounts for 94.9% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2019 at $16,860 and has fallen 99.8% since, to $42 in 2025. Among family medicine clinicians in OR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 89 payments — averaging $273.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$23K
- Sanofi-aventis U.S. LLC$281
- AbbVie$222
- Boehringer Ingelheim$156
- Medtronic$152
- Intuitive Surgical$93
- plus $329 from 8 others
Across 23 payments — averaging $20,280 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Amgen$459K
- Novartis$4K
- AstraZeneca$3K
- Astrazeneca UK Limited$882
What the payments were for
- Speaking & faculty fees$20,76085%
- Travel & lodging$1,5847%
- Food & beverage$2,0208%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 52 | $23,131 |
| Sanofi-aventis U.S. LLC | 10 | $281 |
| AbbVie | 6 | $222 |
| Boehringer Ingelheim | 4 | $156 |
| Medtronic | 2 | $152 |
| Intuitive Surgical | 1 | $93 |
| Novartis | 5 | $87 |
| Merck | 1 | $87 |
| Biohaven Pharmaceuticals, Inc. | 2 | $35 |
| Daiichi Sankyo Inc. | 2 | $31 |
| Lundbeck LLC | 1 | $30 |
| Viatris Specialty LLC | 1 | $26 |
| AstraZeneca | 1 | $16 |
| Genentech USA, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$24,363 in reported general payments places this provider in the 95th percentile of 1,221 family medicine providers in Oregon.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira PenAdalimumab | 13 | $177,104 |
| Enbrel SureclickEtanercept | 12 | $84,071 |
| Repatha SureclickEvolocumab | 40 | $44,601 |
| EliquisApixaban | 19 | $30,502 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 17 | $2,016 |
| Atorvastatin Calcium | 116 | $1,429 |
| Eszopiclone | 13 | $1,047 |
| Fentanyl | 15 | $861 |
| Doxazosin Mesylate | 32 | $826 |
| Ibuprofen | 26 | $668 |
| Levothyroxine Sodium | 46 | $601 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 31 | $590 |
| Estradiol | 11 | $556 |
| Esomeprazole Magnesium | 11 | $536 |
| Azelastine Hcl | 25 | $535 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Portland
- Robert GobboPortland$53K
- Terena GimmillaroPortland$13K
- Carson BauderPortland$8K
- Alexandra Verdieck DevlaeminckPortland$5K
- Kara KassayPortland$5K
- Whitney RoperPortland$4K
- Eden MillerBend$1.7M
- Anil RajaniHood River$325K
- Stephen NelsonMedford$101K
- Karen KahnAshland$86K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.